9.72
price down icon2.70%   -0.27
after-market After Hours: 9.91 0.19 +1.95%
loading
Nurix Therapeutics Inc stock is traded at $9.72, with a volume of 401.51K. It is down -2.70% in the last 24 hours and down -16.28% over the past month. Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.
See More
Previous Close:
$9.99
Open:
$9.74
24h Volume:
401.51K
Relative Volume:
0.42
Market Cap:
$741.05M
Revenue:
$54.55M
Net Income/Loss:
$-193.57M
P/E Ratio:
-3.3633
EPS:
-2.89
Net Cash Flow:
$-181.86M
1W Performance:
+1.67%
1M Performance:
-16.28%
6M Performance:
-55.92%
1Y Performance:
-35.93%
1-Day Range:
Value
$9.545
$9.86
1-Week Range:
Value
$9.25
$10.14
52-Week Range:
Value
$8.18
$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Name
Name
Nurix Therapeutics Inc
Name
Phone
(415) 660-5320
Name
Address
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Name
Employee
286
Name
Twitter
Name
Next Earnings Date
2025-04-09
Name
Latest SEC Filings
Name
NRIX's Discussions on Twitter

Compare NRIX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NRIX
Nurix Therapeutics Inc
9.72 728.81M 54.55M -193.57M -181.86M -2.89
Biotechnology icon
ONC
Beigene Ltd Adr
241.43 27.03B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.00 112.64B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.335 40.86M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.34 64.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.06 6.07B 0 -153.72M -103.81M -2.00

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-17-25 Initiated Leerink Partners Market Perform
Dec-10-24 Initiated BTIG Research Buy
Dec-06-24 Initiated BMO Capital Markets Outperform
Oct-24-24 Initiated UBS Buy
Oct-11-24 Initiated Jefferies Buy
Sep-06-24 Resumed Robert W. Baird Outperform
Jul-31-24 Initiated Truist Buy
Jun-26-23 Resumed Oppenheimer Outperform
Mar-09-23 Initiated Barclays Overweight
Feb-28-23 Initiated Oppenheimer Outperform
Oct-11-22 Initiated Morgan Stanley Equal-Weight
May-31-22 Upgrade Wells Fargo Equal Weight → Overweight
Feb-10-22 Initiated Wells Fargo Equal Weight
Dec-29-21 Initiated H.C. Wainwright Buy
Oct-14-21 Initiated SVB Leerink Outperform
Jun-04-21 Resumed Robert W. Baird Outperform
Apr-30-21 Resumed Piper Sandler Overweight
Apr-30-21 Initiated RBC Capital Mkts Outperform
Apr-14-21 Initiated Berenberg Buy
Nov-19-20 Initiated Robert W. Baird Outperform
Aug-18-20 Initiated JP Morgan Overweight
Aug-18-20 Initiated Needham Buy
Aug-18-20 Initiated Piper Sandler Overweight
Aug-18-20 Initiated Stifel Buy
View All

Nurix Therapeutics Inc Stock (NRIX) Latest News

pulisher
03:04 AM

Point72 Asset Management L.P. Buys Shares of 872,959 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

03:04 AM
pulisher
12:42 PM

D. E. Shaw & Co. Inc. Acquires 40,001 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

12:42 PM
pulisher
May 21, 2025

Deutsche Bank AG Sells 323,485 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Soleus Capital Management L.P. Has $39.62 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

97,889 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by Velan Capital Investment Management LP - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Vestal Point Capital LP Purchases 60,000 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Northern Trust Corp Grows Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 20, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Jacobs Levy Equity Management Inc. Buys Shares of 229,369 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 20, 2025
pulisher
May 19, 2025

Nurix Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

May 19, 2025
pulisher
May 19, 2025

Nurix Therapeutics reports stockholder voting results - Investing.com

May 19, 2025
pulisher
May 19, 2025

Ensign Peak Advisors Inc Acquires 194,673 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is Patient Square Capital LP's 6th Largest Position - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Parkman Healthcare Partners LLC Has $10.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 19, 2025
pulisher
May 17, 2025

Cubist Systematic Strategies LLC Acquires Shares of 124,025 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 17, 2025
pulisher
May 17, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Integral Health Asset Management LLC - MarketBeat

May 17, 2025
pulisher
May 16, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listin - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 16, 2025
pulisher
May 16, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 15, 2025

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - TradingView

May 15, 2025
pulisher
May 14, 2025

Nurix Therapeutics Announces Presentations of Clinical Data at t - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Nurix Therapeutics to Present Phase 1a/b Clinical Trial Data on Bexobrutideg (NX-5948) for CLL and Waldenström Macroglobulinemia at EHA 2025 and 18-ICML Conferences - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Breakthrough Blood Cancer Treatment: Nurix's BTK Degrader Shows Promising Clinical Results in CLL Patients - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Where are the Opportunities in (NRIX) - news.stocktradersdaily.com

May 13, 2025
pulisher
May 13, 2025

Why Nurix Therapeutics (NRIX) Is Among the Best Low Priced Biotech Stocks to Buy Now - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

10 Best Low Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

Shareholders Will Probably Hold Off On Increasing Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) CEO Compensation For The Time Being - simplywall.st

May 12, 2025
pulisher
May 12, 2025

Voya Investment Management LLC Acquires 34,811 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 12, 2025
pulisher
May 10, 2025

135,903 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by First Trust Advisors LP - MarketBeat

May 10, 2025
pulisher
May 10, 2025

Raymond James Financial Inc. Takes $1.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 10, 2025
pulisher
May 09, 2025

Deep Track Capital LP Sells 868,104 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 09, 2025
pulisher
May 07, 2025

Invesco Ltd. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Boxer Capital Management LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 07, 2025
pulisher
May 06, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by JPMorgan Chase & Co. - MarketBeat

May 06, 2025
pulisher
May 06, 2025

RA Capital Management L.P. Acquires Shares of 1,333,333 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 06, 2025
pulisher
May 05, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat

May 05, 2025
pulisher
May 04, 2025

Needham & Company LLC Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Darwin Global Management Ltd. Invests $3.08 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Schonfeld Strategic Advisors LLC Boosts Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 04, 2025
pulisher
May 03, 2025

Lord Abbett & CO. LLC Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 03, 2025
pulisher
May 03, 2025

(NRIX) Trading Signals - news.stocktradersdaily.com

May 03, 2025

Nurix Therapeutics Inc Stock (NRIX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price down icon 17.27%
$31.32
price down icon 3.63%
$587.61
price up icon 1.06%
$289.96
price up icon 0.33%
$4.25
price up icon 0.48%
$75.06
price up icon 3.26%
Cap:     |  Volume (24h):